| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977757 | Brachytherapy | 2012 | 5 Pages |
Abstract
With one of the largest patient populations to date comparing WBI and APBI, no difference in RR or OS was noted between WBI and APBI treatment. Until the publication of prospective Phase III trials, these data support the continued use of APBI on protocol and off protocol in appropriately selected patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Chirag Shah, J. Ben Wilkinson, Maureen Lyden, Alfred Mbah, Martin Keisch, Peter Beitsch, Frank A. Vicini,